Background Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease worldwide. The increasing prevalence of NAFLD mirrors that of obesity and type 2 …

Nonalcoholic fatty liver disease (NAFLD) has become the most prevalent liver disease
worldwide. Despite its high prevalence and rising incidence, there are currently no specific …

beneficial for the liver. This is all that is required for patients with simple steatosis who can
be managed by general or primary care physicians in view of the largely benign prognosis …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
and has an estimated global prevalence of 25%. NAFLD is found in up to 80% of people …

Psoriasis is a chronic inflammatory disease that affects 2–3% of the population worldwide. It
is associated with plaques, psoriatic arthritis, and metabolic syndrome and its components …

Nonalcoholic fatty liver disease (NAFLD) is a global epidemic that is likely to become the
most common cause of chronic liver disease in the next decade, worldwide. Though …

Introduction: A number of researches have explored the association between obesity and
nonalcoholic fatty liver disease (NAFLD) liver function, histopathology, complications …

Nonalcoholic fatty liver disease (NAFLD) is considered the most common liver disorder in
the Western world. It is commonly associated with insulin resistance, obesity, dyslipidaemia …

Non-alcoholic fatty liver (NAFLD) is the most common liver disease worldwide, progressing
from simple steatosis to necroinflammation and fibrosis (leading to non-alcoholic …

Nonalcoholic fatty liver disease (NAFLD) is a chronic illness with multiple consequences.
The spectrum of disease ranges from simple steatosis, with benign prognosis, to a …